Stock Of The Day: Where Will The Eli Lilly Rally End?
Stock Of The Day: Where Will The Eli Lilly Rally End?
Shares of Eli Lilly and Company (NYSE:LLY) are trading higher on Wednesday. The company said that its Zepbound drug was more effective in helping adults with obesity lose weight than Novo Nordisk A/S's (NYSE:NVO) Wegovy. It cited data from a phase 3b trial.
禮來公司(NYSE:LLY)的股票週三上漲。該公司表示,其Zepbound藥物在幫助肥胖成人減肥方面比諾和諾的(NYSE:NVO)Wegovy更有效。據稱,這是從第30億階段試驗的數據。
But the rally may be short-lived. This is why Eli Lilly is our Stock of the Day.
但上漲可能是短暫的。這就是爲什麼Eli Lilly是我們的股票之選。
The company said that using Zepbound led to a 20.2% weight loss. This was significantly better than the 13.7% weight loss that users of Wegovy experienced. But despite these results, technical analysis dynamics may put a ceiling over the stock.
該公司表示使用Zepbound導致體重減輕20.2%。這明顯優於使用Wegovy的用戶經歷的13.7%體重減輕。但儘管有這些結果,技術面的動態可能對股票形成壓力。
'Sell at former peaks' is an old expression on Wall Street. As you can see on the chart, this would have been good advice for traders of Eli Lilly.
「在前峯賣出」是華爾街的一句老話。正如您在圖表上所看到的,這對禮來的交易者來說是一個好建議。
Read Also: Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
閱讀更多:減肥藥之爭升級:安進挑戰禮來、諾和諾的主導地位
In July, the shares formed a peak around the $956.90 level. After a selloff, the shares returned to this level in late August. Once again, they found resistance and reversed.
7月,股價在956.90美元水平附近形成峯值。在一輪拋售後,股價在8月下旬回歸到這一水平。再次遇到阻力並出現逆轉。
In late September, the stock peaked around the $937.40 level. When the shares rallied back to this price in the middle of October, they ran into resistance again and another selloff followed.
9月下旬,股價在937.40美元水平附近觸及頂峯。當股價在10月中旬升至這個價格時,再次遇到阻力,隨之而來又一輪拋售。
The most recent peak in early November happened around the $846.50 level. Now the shares are approaching this level again. There is a good chance they run into resistance and reverse and head lower.
11月初最近的高峰約在846.50美元水平附近。現在股票再次接近這個水平。有很大的可能性會遇到支撐位並且逆轉向下。
In the financial markets, there tends to be resistance at price levels that were previously resistance because of investment psychology. It is due to 'buyer's remorse'.
在金融市場中,以前形成支撐位的價格水平通常會遇到阻力,這是由於投資心理學。這是由於「買方後悔」。
There are traders and investors who purchased shares while they were at peaks who regret doing so when the price drops soon after. A number of them believe their decision to buy was a mistake and decide to sell.
有些交易員和投資者在股票到達高峰時購買股票,但在價格之後不久下跌後後悔。其中一些人認爲自己買入是錯誤的決定,於是決定賣出。
But they don't want to lose money. So, they decide to be patient and hold onto their positions. If they can eventually get out at breakeven they will.
但他們不想虧錢。因此,他們決定耐心持有他們的頭寸。如果他們最終能夠達到保本價位,他們將賣出。
As a result, if and when the stock rallies back to their buy price, they place sell orders. If there is a large number of these remorseful buyers placing sell orders at the level that was previously a peak, it will create resistance again.
因此,如果股票反彈回他們的買入價位時,他們會提出賣出訂單。如果有大量這些後悔的買家在以前的高峰水平上提出賣出訂單,那麼會再次形成阻力。
Some old Wall Street sayings can be good advice. 'Sell at former peaks' is one of them. The chart of Eli Lilly proves it.
一些古老的華爾街格言可能是個好建議。「在前高位賣出」就是其中之一。愛力健的圖表證明了這一點。
- 'Big Short' Trader Danny Moses Gives Up On Shorting Tesla, Says It Is 'Very Difficult To Short A Name That Is Not Trading On Fundamentals'
- 「大空頭」交易員丹尼·摩西放棄對特斯拉做空,表示「非常難以做空一個不基於基本面交易的名字」。
Image: Shutterstock
圖片:shutterstock